{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:49:41Z","timestamp":1771922981747,"version":"3.50.1"},"reference-count":16,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Cancer incidence and mortality continue to increase rapidly worldwide [...]<\/jats:p>","DOI":"10.3390\/pharmaceutics13020275","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T20:56:21Z","timestamp":1613681781000},"page":"275","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Novel Anticancer Strategies"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-5779","authenticated-orcid":false,"given":"Hassan","family":"Bousbaa","sequence":"first","affiliation":[{"name":"CESPU, Instituto de Investiga\u00e7\u00e3o e Forma\u00e7\u00e3o Avan\u00e7ada Em Ci\u00eancias e Tecnologias da Sa\u00fade, Instituto Universit\u00e1rio de Ci\u00eancias da Sa\u00fade, 4585-116 Gandra PRD, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Abouaitah, K., and Lojkowski, W. (2021). Delivery of natural agents by means of mesoporous silica nanospheres as a promising anticancer strategy. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13020143"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Alven, S., and Aderibigbe, B.A. (2020). The therapeutic efficacy of dendrimer and micelle formulations for breast cancer treatment. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12121212"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Jin, I.S., Jo, M.J., Park, C.W., Chung, Y.B., Kim, J.S., and Shin, D.H. (2020). Physicochemical, pharmacokinetic, and toxicity evaluation of soluplus\u00ae polymeric micelles encapsulating fenbendazole. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12101000"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Paranthaman, S., Shivananjegowda, M.G., Mahadev, M., Moin, A., Nanjappa, S.H., Nanjaiyah, N., Chidambaram, S.B., and Gowda, D.V. (2020). Nanodelivery systems targeting epidermal growth factor receptors for glioma management. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12121198"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Choi, Y., Han, H., Jeon, S., Yoon, H.Y., Kim, H., Kwon, I.C., and Kim, K. (2020). Deep tumor penetration of doxorubicin-loaded glycol chitosan nanoparticles using high-intensity focused ultrasound. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12100974"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Haugse, R., Langer, A., Murvold, E.T., Costea, D.E., Gjertsen, B.T., Gilja, O.H., Kotopoulis, S., de Garibay, G.R., and McCormack, E. (2020). Low-intensity sonoporation-induced intracellular signalling of pancreatic cancer cells, fibroblasts and endothelial cells. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12111058"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Pinto, B., Henriques, A.C., Silva, P.M.A., and Bousbaa, H. (2020). Three-dimensional spheroids as in vitro preclinical models for cancer research. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12121186"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Hernandez-Oller, L., Seras-Franzoso, J., Andrade, F., Rafael, D., Abasolo, I., Gener, P., and Schwartz, S. (2020). Extracellular vesicles as drug delivery systems in cancer. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12121146"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Park, J., Lee, H., Youn, Y.S., Oh, K.T., and Lee, E.S. (2020). Tumor-homing ph-sensitive extracellular vesicles for targeting heterogeneous tumors. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12040372"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"D\u00f3kus, L.E., Lajk\u00f3, E., Ran\u00f0elovi\u0107, I., Mez\u0151, D., Schlosser, G., K\u0151hidai, L., T\u00f3v\u00e1ri, J., and Mez\u0151, G. (2020). Phage display-based homing peptide-daunomycin conjugates for selective drug targeting to panc-1 pancreatic cancer. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12060576"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Abouzayed, A., Tano, H., Nagy, \u00c1., Rinne, S.S., Wadeea, F., Kumar, S., Westerlund, K., Tolmachev, V., Karlstr\u00f6m, A.E., and Orlova, A. (2020). Preclinical evaluation of the grpr-targeting antagonist rm26 conjugated to the albumin-binding domain for grpr-targeting therapy of cancer. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12100977"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Quiroz-Reyes, A.G., Islas, J.F., Delgado-Gonzalez, P., Franco-Villarreal, H., and Garza-Trevi\u00f1o, E.N. (2021). Therapeutic approaches for metastases from colorectal cancer and pancreatic ductal carcinoma. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13010103"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Noh, J.J., Kim, M.S., Cho, Y.J., Jeong, S.Y., Lee, Y.Y., Ryu, J.Y., Choi, J.J., Bae, I., Wu, Z., and Kim, B.G. (2020). Anti-cancer activity of as4 o6 and its efficacy in a series of patient-derived xenografts for human cervical cancer. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12100987"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sicard, G., Paris, C., Giacometti, S., Rodallec, A., Ciccolini, J., Rocchi, P., and Fanciullino, R. (2020). Enhanced antisense oligonucleotide delivery using cationic liposomes grafted with trastuzumab: A proof-of-concept study in prostate cancer. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12121166"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Sicard, G., Fina, F., Fanciullino, R., Barlesi, F., and Ciccolini, J. (2020). Like a rolling stone: Sting-CGAS pathway and cell-free DNA as biomarkers for combinatorial immunotherapy. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12080758"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Byun, J.H., Yoon, I.S., Jeong, Y.D., Kim, S., and Jung, I.H. (2020). A tumor-immune interaction model for synergistic combinations of anti pd-l1 and ionizing irradiation treatment. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12090830"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/2\/275\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:25:29Z","timestamp":1760160329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/2\/275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2]]}},"alternative-id":["pharmaceutics13020275"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13020275","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]}}}